DE69418865D1 - Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten - Google Patents
Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthaltenInfo
- Publication number
- DE69418865D1 DE69418865D1 DE69418865T DE69418865T DE69418865D1 DE 69418865 D1 DE69418865 D1 DE 69418865D1 DE 69418865 T DE69418865 T DE 69418865T DE 69418865 T DE69418865 T DE 69418865T DE 69418865 D1 DE69418865 D1 DE 69418865D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- east
- compositions containing
- containing pdgf
- growth compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3832593A | 1993-03-29 | 1993-03-29 | |
PCT/US1994/003331 WO1994022463A1 (en) | 1993-03-29 | 1994-03-29 | Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69418865D1 true DE69418865D1 (de) | 1999-07-08 |
DE69418865T2 DE69418865T2 (de) | 2000-02-17 |
Family
ID=21899306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69418865T Expired - Lifetime DE69418865T2 (de) | 1993-03-29 | 1994-03-29 | Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten |
Country Status (14)
Country | Link |
---|---|
US (1) | US5533836A (de) |
EP (1) | EP0691849B1 (de) |
JP (1) | JP3699111B2 (de) |
KR (1) | KR960701648A (de) |
CN (1) | CN1104257C (de) |
AT (1) | ATE180674T1 (de) |
AU (1) | AU681879B2 (de) |
CA (1) | CA2159449C (de) |
DE (1) | DE69418865T2 (de) |
DK (1) | DK0691849T3 (de) |
ES (1) | ES2132399T3 (de) |
GR (1) | GR3030402T3 (de) |
RU (1) | RU2140282C1 (de) |
WO (1) | WO1994022463A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700289A (en) * | 1995-10-20 | 1997-12-23 | North Shore University Hospital Research Corporation | Tissue-engineered bone repair using cultured periosteal cells |
JP2000514048A (ja) * | 1996-06-20 | 2000-10-24 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | 薬理学的活性調製物を提供するための化合物および方法ならびにそれらの使用 |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US6042855A (en) * | 1997-06-27 | 2000-03-28 | United States Of America (Usda) | Use of vitamin D, its metabolites and analogs to improve tenderness of meat and meat products |
AU748002B2 (en) * | 1997-12-31 | 2002-05-30 | Depuy Orthopaedics, Inc. | Osteopontin-based compositions for enhancing bone repair |
US6551355B1 (en) | 1998-08-14 | 2003-04-22 | Cambridge Scientific, Inc. | Tissue transplant coated with biocompatible biodegradable polymer |
US6663870B2 (en) * | 1998-12-07 | 2003-12-16 | Zymogenetics, Inc. | Methods for promoting growth of bone using zvegf3 |
US6468543B1 (en) * | 1999-05-03 | 2002-10-22 | Zymogenetics, Inc. | Methods for promoting growth of bone using ZVEGF4 |
AU1430601A (en) * | 1999-11-02 | 2001-05-14 | Eli Lilly And Company | Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
EP2431060B1 (de) * | 2005-11-17 | 2020-04-08 | BioMimetic Therapeutics, LLC | Kiefer- und Gesichtsknochenerweiterung mithilfe von RHPDGF-BB und einer biokompatiblen Matrix |
EP1991282B1 (de) | 2006-02-09 | 2013-06-19 | BioMimetic Therapeutics, LLC | Zusammensetzungen und verfahren zur behandlung von knochen |
CA2656278C (en) | 2006-06-30 | 2016-02-09 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating rotator cuff injuries |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
JP5552315B2 (ja) | 2006-11-03 | 2014-07-16 | バイオミメティック セラピューティクス, エルエルシー | アースロデティック術のための組成物および方法 |
CN102014977B (zh) | 2008-02-07 | 2015-09-02 | 生物模拟治疗有限责任公司 | 用于牵引成骨术的组合物和方法 |
KR20110013450A (ko) * | 2008-05-07 | 2011-02-09 | 본 테라퓨틱스 소시에테아노님 | 간엽 줄기 세포 및 골-형성 세포 |
US20110142810A1 (en) * | 2008-08-19 | 2011-06-16 | Osaka University | Cell preparation for bone tissue regeneration |
AU2009291828C1 (en) | 2008-09-09 | 2016-03-17 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
BR112012020566B1 (pt) | 2010-02-22 | 2021-09-21 | Biomimetic Therapeutics, Llc | Composição de fator de crescimento derivado de plaqueta |
EP2823787B1 (de) * | 2012-02-01 | 2019-01-09 | Organ Technologies, Inc. | Zahnimplantat und herstellungsverfahren dafür |
CA2962954A1 (en) | 2014-10-14 | 2016-04-21 | Samuel Lynch | Compositions for treating wounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4264512A (en) * | 1975-09-29 | 1981-04-28 | The Regents Of The University Of California | 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof |
US5124316A (en) * | 1986-11-14 | 1992-06-23 | President And Fellows Of Harvard College | Method for periodontal regeneration |
CA1322714C (en) * | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
US5254538A (en) * | 1989-10-04 | 1993-10-19 | Trustees Of Boston University | Method of treating periodontal disease |
CZ282231B6 (cs) * | 1991-06-05 | 1997-06-11 | The Procter And Gamble Company | Prostředek na generování nového růstu kosti v savci |
US5129691A (en) * | 1991-08-20 | 1992-07-14 | Mcfarlen Jonn | Gate latch control device |
-
1994
- 1994-03-29 AU AU64171/94A patent/AU681879B2/en not_active Expired
- 1994-03-29 EP EP94911725A patent/EP0691849B1/de not_active Expired - Lifetime
- 1994-03-29 CA CA002159449A patent/CA2159449C/en not_active Expired - Lifetime
- 1994-03-29 KR KR1019950704221A patent/KR960701648A/ko not_active Application Discontinuation
- 1994-03-29 JP JP52224994A patent/JP3699111B2/ja not_active Expired - Lifetime
- 1994-03-29 DE DE69418865T patent/DE69418865T2/de not_active Expired - Lifetime
- 1994-03-29 WO PCT/US1994/003331 patent/WO1994022463A1/en active IP Right Grant
- 1994-03-29 CN CN94191916A patent/CN1104257C/zh not_active Expired - Lifetime
- 1994-03-29 DK DK94911725T patent/DK0691849T3/da active
- 1994-03-29 AT AT94911725T patent/ATE180674T1/de active
- 1994-03-29 ES ES94911725T patent/ES2132399T3/es not_active Expired - Lifetime
- 1994-03-29 RU RU95119807A patent/RU2140282C1/ru active
-
1995
- 1995-03-22 US US08/408,331 patent/US5533836A/en not_active Expired - Lifetime
-
1999
- 1999-06-03 GR GR990401332T patent/GR3030402T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0691849T3 (da) | 1999-12-13 |
ES2132399T3 (es) | 1999-08-16 |
CN1121693A (zh) | 1996-05-01 |
AU6417194A (en) | 1994-10-24 |
JPH08508499A (ja) | 1996-09-10 |
WO1994022463A1 (en) | 1994-10-13 |
AU681879B2 (en) | 1997-09-11 |
KR960701648A (ko) | 1996-03-28 |
EP0691849B1 (de) | 1999-06-02 |
CA2159449C (en) | 1999-09-14 |
EP0691849A1 (de) | 1996-01-17 |
RU2140282C1 (ru) | 1999-10-27 |
JP3699111B2 (ja) | 2005-09-28 |
CN1104257C (zh) | 2003-04-02 |
DE69418865T2 (de) | 2000-02-17 |
US5533836A (en) | 1996-07-09 |
ATE180674T1 (de) | 1999-06-15 |
GR3030402T3 (en) | 1999-09-30 |
CA2159449A1 (en) | 1994-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69418865D1 (de) | Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten | |
DE69028535T2 (de) | Herstellung des vaskulären endothelialen zellwachstumsfaktors | |
ES2007625A6 (es) | Un procedimiento para la produccion de una proteina para huesos y cartilagos. | |
EP0339607A3 (en) | Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant | |
UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
DE69429450T2 (de) | Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung | |
LV10180A (lv) | Farmaceitiska kompozicija | |
DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
ATE210992T1 (de) | Injizierbare zusammensetzungen zur vergrösserung von weichgewebe | |
DE69025922T2 (de) | Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen | |
NO921875D0 (no) | Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst | |
ATE186840T1 (de) | Zusammensetzungen und methoden zur wundbehandlung | |
ATE120203T1 (de) | Methoden und zusammensetzungen für heilung von knochen. | |
AT338429B (de) | Zur verankerung von implantaten und gelenkendoprothesen im knochen dienende mischung | |
DE68919361T2 (de) | Therapeutische zusammensetzungen für die behandlung von myocard-infarkten. | |
NL7601628A (nl) | Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese. | |
ATE228171T1 (de) | Mikrobielle herstellung von vitamin b12 sowie herstellung und verwendung von zusammensetzungen die vitamin b12 in hohen konzentrationen enthalten | |
DE3690341D2 (en) | Bone cement | |
EP0097057A3 (en) | Method of producing human epidermal growth factor and pharmaceutical composition containing it | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
IT1249004B (it) | Metodo e composizione per la stimolazione della crescita di vegetali | |
ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
HUT47591A (en) | Process for production of nucleozides with healing effect and medical compositions containing them | |
CA846878A (en) | Method of preparing surgical prosthetic implants for the repair and replacement of vascular organs and tissues in human bodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |